TradeLink Capital’s Idexx Laboratories IDXX Stock Holding History

TradeLink Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-1,400	Closed	-$63K	–	310
2013 Q2	$63K	Buy	+1,400	New	+$61.2K	0.02%	396

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TradeLink Capital's IDXX Position: Q3 2013 in Review

TradeLink Capital sold out of Idexx Laboratories (IDXX) in Q3 2013, closing a stake of 1,400 shares — an estimated $63K sold.

TradeLink Capital first reported a position in IDXX in Q2 2013 and held it in 1 quarter. The position peaked at $63K in Q2 2013. 274 funds tracked by Wall St. Rank hold IDXX as of Q3 2013.

TradeLink Capital reported no remaining Idexx Laboratories position as of Q3 2013 after selling out during the quarter.
TradeLink Capital sold 1,400 Idexx Laboratories shares in Q3 2013, an estimated $63K.
TradeLink Capital first reported a position in Idexx Laboratories in Q2 2013 and held it in 1 quarter.
TradeLink Capital's Idexx Laboratories position peaked at $63K in Q2 2013.
274 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2013.

Based on TradeLink Capital's 13F filing for Q3 2013, filed 12 Nov 2013.